The Latest Cardiac and Vascular News
VANCOUVER and MINNEAPOLIS, March 11, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), today reported financial results for the fourth quarter and fiscal year ended December 31, 2020. Fourth Quarter Highlights Generated revenue of $514,000 in the quarter and $1.96 million for the full year as Reducer […]
U.S. pivotal study to determine safety and effectiveness of the WRAPSODY Endovascular Stent Graft System in the treatment of dialysis outflow circuit stenosis or occlusion SOUTH JORDAN, Utah, March 11, 2021 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. announced today that Lisa Anderson, Ph.D., has been elevated to the role of CEO. Dr. Anderson succeeds William Edelman, who has served as Chairman and CEO since 2012 and recently announced his retirement. John Cammett, member of the Board for over three years, will assume the […]
LAVAL, Quebec–(BUSINESS WIRE)–Altasciences is proud to have conducted preclinical studies for Verve Therapeutics that support the development and advancement of Verve’s gene editing approach to treating cardiovascular diseases. Altasciences’ Seattle team performed intravenous preclinical studies, including supporting analyses of pharmacodynamic markers and whole liver DNA editing, in non-human primates, that show […]
MALVERN, Pa. & SAN DIEGO–(BUSINESS WIRE)–PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, and BioVectra Inc., an innovative global contract development and manufacturing organization (CDMO), today announced a commercial scale supply agreement for the production of bentracimab, PhaseBio’s […]
Organizations to develop roadmap for hospitals, health systems and practices to improve clinical, financial and operational performance while transforming patient care Amsterdam, the Netherlands and Washington, D.C., U.S. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, the American College of Cardiology (ACC), whose mission is to transform […]
TUSTIN, Calif.–(BUSINESS WIRE)–Canon Medical Systems USA, Inc. has earned a top award for XR R&F service according to data gathered during IMV’s 2020 ServiceTrak customer surveys. The award is given to imaging system providers that receive the highest percentage of highly satisfied customer responses. “It is an honor to add this […]
WARREN, N.J., March 11, 2021 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial results for the fourth quarter and year ended December 31, 2020. “Bellerophon continues […]
New educational app from the leading cardiopulmonary digital health company offers clinical screening resources and real world application on identifying heart and lung abnormalities OAKLAND, Calif., March 11, 2021 (GLOBE NEWSWIRE) — Eko, a cardiopulmonary digital health company, today announced the launch of its clinical education initiative. Eko Academy, a free […]
MIAMI, March 11, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, announced today that the U.S. Food & Drug Administration (FDA) has granted expanded access approval for the administration of Longeveron’s investigational cell […]
